Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
Apar Industries Limited - Shareholders meeting

2018-07-12 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
APARINDS 532259

0
Apar Industries Limited - AGM/Book Closure

2018-07-12 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
APARINDS 532259

0
Atlan Holdings, Rohas Tecnic, N2N Connect, Adventa, Top Glove, Versatile Creative, LPI Capital and Econpile

2018-07-09 theedgemarkets
KUALA LUMPUR (July 9): Based on corporate announcements and news flow today, stocks that will draw some attention on Tuesday (July 10) may include: Atlan Holdings, Rohas Tecnic, N2N Connect, Adventa, Top Glove, Versatile Creative, LPI Capital and Econpile.
TGLVY 4995 APARINDS 0108 8621 7113 5253 TPGVF 5SO BSMAF 532259 1818

0
Rohas Tecnic JV wins RM37.8 mil transmission lines reconductoring contract

2018-07-09 theedgemarkets
KUALA LUMPUR (July 9): Rohas Tecnic Bhd has bagged a joint-venture contract for the reconductoring of three existing transmission lines for a combination of US$7.52 million and 157.73 million Bangladeshi Taka (about RM37.8 million).
APARINDS 532259

8
Podcast | A morning walk down Dalal Street: Stay cautious as long as Nifty trades below 10,700

2018-07-03 moneycontrol
D-Street witnessed a smart recovery in the second half of the session on Monday but it failed to close above 10,700 levels. The index closed below its crucial short-term moving averages such as 5-EMA, 13-EMA as well as 50-EMA in a single session.
BAJAJ-AUTO 500408 APARINDS 500116 DALMIABHA IDBI FORCEMOT 532977 SRTRANSFIN 532259 511218 FINOLEXIND 533309 SRRQY TATAELXSI 500940 500570 TATAMOTORS 500033 TTM

37
Podcast | An evening walk down Dalal Street: Sensex falls over 150 points; nearly 300 stocks hit 52-week low

2018-07-02 moneycontrol
The S&P BSE Sensex reversed half of Friday's gains to end the first session of the week lower by half a percent on Monday, dragged by global weakness due to trade tensions and political uncertainty in Germany.
BAJAJ-AUTO 500820 532938 KAJARIACER CAPF 532977 BHRQY ASIANPAINT 533278 532259 532343 500470 533309 500233 LNSTY HDFCBANK HEROMOTOCO 500477 BHARTIARTL CLNDY 509488 500033 ASHOKLEY APARINDS TVSMOTOR GRAPHITE DALMIABHA IBN FORCEMOT AKLD 500182 FINOLEXIND 532454 ICICIBANK TTST TATASTEEL TATLY HDB 532174 500180 500940 HRTQY AKLS COALINDIA

0
Apar Industries Limited - Updates

2018-06-06 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
APARINDS 532259

0
Apar Industries Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-06-05 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
APARINDS 532259

0
Apar Industries Limited - Disclosure under SEBI Takeover Regulations

2018-06-01 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
APARINDS 532259

0
Apar Industries Limited - Investor Presentation

2018-05-31 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
APARINDS 532259

0
Apar Industries Limited - Financial Result Updates

2018-05-30 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
APARINDS 532259

0
Apar Industries Limited - Disclosure under SEBI Takeover Regulations

2018-05-15 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
APARINDS 532259

0
Apar Industries Limited - Disclosure under SEBI Takeover Regulations

2018-05-08 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
APARINDS 532259

0
Apar Industries Limited - Disclosure under SEBI Takeover Regulations

2018-05-07 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
APARINDS 532259

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...